Detalhe da pesquisa
1.
Characterization of herpes simplex virus 1 strains as platforms for the development of oncolytic viruses against liver cancer.
Liver Int
; 31(10): 1542-53, 2011 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-22093330
2.
Novel tumour-specific promoters for transcriptional targeting of hepatocellular carcinoma by herpes simplex virus vectors.
J Gene Med
; 12(12): 956-67, 2010 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-21104973
3.
Targeting Poxvirus Decapping Enzymes and mRNA Decay to Generate an Effective Oncolytic Virus.
Mol Ther Oncolytics
; 8: 71-81, 2018 Mar 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-29888320
4.
Shared ancestry of herpes simplex virus 1 strain Patton with recent clinical isolates from Asia and with strain KOS63.
Virology
; 512: 124-131, 2017 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-28957690
5.
Modeling HSV-1 Latency in Human Embryonic Stem Cell-Derived Neurons.
Pathogens
; 6(2)2017 Jun 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-28594343
6.
Biological characterization of bovine herpesvirus 1 recombinants possessing the vaccine glycoprotein E negative phenotype.
Vet Microbiol
; 113(3-4): 283-91, 2006 Mar 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-16321480
7.
CD8(+) T-cell Immune Evasion Enables Oncolytic Virus Immunotherapy.
EBioMedicine
; 5: 59-67, 2016 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-27077112
8.
Intraspecific bovine herpesvirus 1 recombinants carrying glycoprotein E deletion as a vaccine marker are virulent in cattle.
J Gen Virol
; 87(Pt 8): 2149-2154, 2006 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-16847110